Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

This study has been terminated.
Sponsor:
Collaborator:
Takeda
Information provided by:
French National Agency for Research on AIDS and Viral Hepatitis
ClinicalTrials.gov Identifier:
NCT00148850
First received: September 7, 2005
Last updated: October 19, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: October 2004
  Estimated Primary Completion Date: No date given
No publications provided by French National Agency for Research on AIDS and Viral Hepatitis

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):